Last year, the FDA granted andexanet alfa an accelerated approval as a reversal agent for factor Xa inhibitors, […]
NEJM
1 post
Last year, the FDA granted andexanet alfa an accelerated approval as a reversal agent for factor Xa inhibitors, […]